257 related articles for article (PubMed ID: 15529157)
1. Biomanufacturing, from bust to boom...to bubble?
Thiel KA
Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
[No Abstract] [Full Text] [Related]
2. Changes in the business of culture.
Pissarra Pde N
Nat Biotechnol; 2004 Nov; 22(11):1355-6. PubMed ID: 15529153
[No Abstract] [Full Text] [Related]
3. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
4. The quiet revolution.
Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
[No Abstract] [Full Text] [Related]
5. What's fueling the biotech engine?
Aggarwal S
Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
[No Abstract] [Full Text] [Related]
6. The quiet revolution: outsourcing in pharma.
Crossley R
Drug Discov Today; 2004 Aug; 9(16):694. PubMed ID: 15341780
[No Abstract] [Full Text] [Related]
7. UK industry consolidation is slow despite big merger.
Mitchell P
Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
[No Abstract] [Full Text] [Related]
8. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
Mahinka SP; Sanzo KM
Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
[No Abstract] [Full Text] [Related]
9. Create products by going virtual.
Hogan J
Med Device Technol; 2005 Nov; 16(9):38-9. PubMed ID: 16438448
[TBL] [Abstract][Full Text] [Related]
10. Biotech drug market steadily expands.
Lawrence S
Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
[No Abstract] [Full Text] [Related]
11. Bugs or drugs, tortoises or hares?
Jacobs T
Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079
[No Abstract] [Full Text] [Related]
12. The promise of the East: India and China as R&D options.
Goodall S; Janssens B; Wagner K; Wong J; Woods W; Yeh M
Nat Biotechnol; 2006 Sep; 24(9):1061-4. PubMed ID: 17061321
[No Abstract] [Full Text] [Related]
13. Recombinant protein therapeutics--success rates, market trends and values to 2010.
Pavlou AK; Reichert JM
Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
[No Abstract] [Full Text] [Related]
14. Can China bring its own pipeline to the market?
Louët S
Nat Biotechnol; 2004 Dec; 22(12):1497-9. PubMed ID: 15583646
[No Abstract] [Full Text] [Related]
15. Rediscovering plant-based drugs.
Littleton J; Falcone D; Davies HM
Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
[No Abstract] [Full Text] [Related]
16. Trading on traditional medicines.
Basu P
Nat Biotechnol; 2004 Mar; 22(3):263-5. PubMed ID: 14990941
[No Abstract] [Full Text] [Related]
17. Commercializing nanotechnology.
Mazzola L
Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
[No Abstract] [Full Text] [Related]
18. Deconstructing Myogen's market cap.
Ransom J
Nat Biotechnol; 2006 Mar; 24(3):227-8. PubMed ID: 16525363
[No Abstract] [Full Text] [Related]
19. Cambridge: Europe's leading location for biotechnology.
Walker J
Drug Discov Today; 2005 Jul; 10(14):956-9. PubMed ID: 16023052
[No Abstract] [Full Text] [Related]
20. Seizures of Canadian drugs rise as Congress, Customs spar.
Carreyrou J
Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501
[No Abstract] [Full Text] [Related]
[Next] [New Search]